Ferumoxytol nanozymes effectively target chronic biofilm infections in apical periodontitis
Journal of Clinical Investigation · 03.02.2025 · 135 (3)
DOI: 10.1172/jci183576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 26.11.2024. Verfasst von Alaa Babeer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endodontics, School of Dental Medicine and. Hauptthemen laut MEDLINE: Biofilms, Periapical Periodontitis, Enterococcus faecalis, Fusobacterium nucleatum. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, National Institute for Dental and Craniofacial Research.
Abstract (Originalsprache)
Bacterial biofilms are pervasive and recalcitrant to current antimicrobials, causing numerous infections. Iron oxide nanozymes, including an FDA-approved formulation, ferumoxytol (FMX), show potential against biofilm infections via catalytic activation of hydrogen peroxide (H 2 O 2 ). However, clinical evidence regarding the efficacy and therapeutic mechanisms of FMX is lacking. Here, we investigate whether FMX nanozymes can treat chronic biofilm infections and compare their bioactivity to that of the gold standard sodium hypochlorite (NaOCl), a potent but caustic disinfectant. Clinical performance was assessed in patients with apical periodontitis, an intractable endodontic infection affecting half of the global adult population. Data show robust antibiofilm activity by a single application of FMX with H 2 O 2 achieving results comparable to those seen with NaOCl without adverse effects. FMX binds efficiently to the bacterial pathogens Enterococcus faecalis and Fusobacterium nucleatum and remains catalytically active without being affected by dental tissues. This allows for effective eradication of endodontic biofilms via on-site free radical generation without inducing cytotoxicity. Unexpectedly, FMX promotes growth of stem cells of the apical papilla (SCAPs), with transcriptomic analyses revealing upregulation of proliferation-associated pathways and downregulation of cell cycle suppressor genes. Notably, FMX activates SCAP pluripotency and WNT/NOTCH signaling that induces its osteogenic capacity. Together, these results show that FMX nanozymes are clinically effective against severe chronic biofilm infection with pathogen targeting and unique stem cell–stimulatory properties, offering a regenerative approach to antimicrobial therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endodontics, School of Dental Medicine and.
- Biofilm Research Laboratories, Levy Center for Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Oral Biology, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Preventive and Restorative Sciences, School of Dental Medicine.
- Center for Innovation & Precision Dentistry, School of Dental Medicine, School of Engineering and Applied Sciences.
- Department of Chemical and Biomolecular Engineering, School of Engineering and Applied Sciences, and.
Förderung
- NIDCR NIH HHS
- National Institute for Dental and Craniofacial Research
Zitieren
APA
Babeer, A., Liu, Y., Ren, Z., Xiang, Z., Oh, M. J., Pandey, N. K., Simon-Soro, A., Huang, R., Karabucak, B., Cormode, D. P., Chen, C., & Koo, H. (2025). Ferumoxytol nanozymes effectively target chronic biofilm infections in apical periodontitis. Journal of Clinical Investigation, 135(3). https://doi.org/10.1172/jci183576
Vancouver
Babeer A, Liu Y, Ren Z, Xiang Z, Oh MJ, Pandey NK, et al. Ferumoxytol nanozymes effectively target chronic biofilm infections in apical periodontitis. Journal of Clinical Investigation. 2025;135(3). doi:10.1172/jci183576
BibTeX
@article{Babeer2025,
author = {Babeer, Alaa and Liu, Yuan and Ren, Zhi and Xiang, Zhenting and Oh, Min Jun and Pandey, Nil Kanatha and Simon-Soro, Aurea and Huang, Ranran and Karabucak, Bekir and Cormode, David P and Chen, Chider and Koo, Hyun},
title = {Ferumoxytol nanozymes effectively target chronic biofilm infections in apical periodontitis},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {3},
doi = {10.1172/jci183576}
}
EUVIMED